From June 2, 2022 to June 30, 2022, the company has repurchased 229,000 shares, representing 0.03% for HKD 0.21 million. With this, the company has completed the repurchase of 229,000 shares, representing 0.03% for HKD 0.21 million under the buyback announced on June 2, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 HKD | 0.00% | +9.09% | -12.41% |
1st Jan change | Capi. | |
---|---|---|
-12.41% | 114M | |
+16.40% | 42.95B | |
+16.92% | 21.38B | |
+20.14% | 15.05B | |
+18.64% | 14.45B | |
+53.58% | 13.04B | |
-0.05% | 6.79B | |
-11.82% | 6.72B | |
-8.87% | 5.73B | |
+11.64% | 5.47B |
- Stock Market
- Equities
- 1652 Stock
- News Fusen Pharmaceutical Company Limited
- Tranche Update on Fusen Pharmaceutical Company Limited's Equity Buyback Plan announced on June 2, 2022.